Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency - PubMed (original) (raw)
Affiliations
- PMID: 19755219
Five month study of percutaneous heart valves in the systemic circulation of sheep using a novel model of aortic insufficiency
Hélène Eltchaninoff et al. EuroIntervention. 2006 Feb.
Abstract
Aims: To study the 5 month performance of a balloon-expandable percutaneous heart valve (PHV) in the systemic circulation of animals.
Methods and results: Moderate-to-severe (>/= grade 3) aortic insufficiency was created in 14 juvenile sheep using a bioptome device. A 23mm PHV was implanted distal to the left subclavian artery (1.78+/-0.18 cm2 area, 27+/-2 mmHg closing gradient). Valve performance was followed angiographically (baseline, 21 weeks) and echocardiographically (baseline, 6, 14, 21 weeks). Animals were euthanized at 21 weeks or at the first sign of valve dysfunction. Four animals died of acute procedural complications (aortic perforation, mitral valve damage, hemothorax, and sheath dissection of brachio-cephalic artery). One animal with a rotated PHV (secondary to aortic dissection) was euthanized at 6 weeks; 3 animals were euthanized at weeks 6 and 14 because of decreased leaflet mobility (normal PHV at autopsy, decreased mobility related to halothane-induced hypotension). Six animals with normal PHV function (1.68+/-0.12 cm2 area, 23+/-4mmHg closing gradient) were euthanized at 21 weeks; pathologic examination revealed no significant PHV abnormalities. Native aortic valve insufficiency was grade 2-4 at 21 weeks.
Conclusion: PHV function remains satisfactory to 21 weeks in the descending aorta. This animal model is valid for chronic study of PHV in the systemic circulation.
Similar articles
- First percutaneous transcatheter aortic valve-in-valve implant with three year follow-up.
Ruiz CE, Laborde JC, Condado JF, Chiam PT, Condado JA. Ruiz CE, et al. Catheter Cardiovasc Interv. 2008 Aug 1;72(2):143-8. doi: 10.1002/ccd.21597. Catheter Cardiovasc Interv. 2008. PMID: 18655115 - Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis.
Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Sebagh L, Bash A, Nusimovici D, Litzler PY, Bessou JP, Leon MB. Cribier A, et al. J Am Coll Cardiol. 2004 Feb 18;43(4):698-703. doi: 10.1016/j.jacc.2003.11.026. J Am Coll Cardiol. 2004. PMID: 14975485 - Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.
Cribier A, Eltchaninoff H, Tron C, Bauer F, Agatiello C, Nercolini D, Tapiero S, Litzler PY, Bessou JP, Babaliaros V. Cribier A, et al. J Am Coll Cardiol. 2006 Mar 21;47(6):1214-23. doi: 10.1016/j.jacc.2006.01.049. Epub 2006 Feb 9. J Am Coll Cardiol. 2006. PMID: 16545654 - New flexible polymeric heart valve prostheses for the mitral and aortic positions.
Daebritz SH, Fausten B, Hermanns B, Franke A, Schroeder J, Groetzner J, Autschbach R, Messmer BJ, Sachweh JS. Daebritz SH, et al. Heart Surg Forum. 2004;7(5):E525-32. doi: 10.1532/HSF98.20041083. Heart Surg Forum. 2004. PMID: 15799940 Review. - [The best of valvular heart disease in 2006].
de Gevigney G; Groupe de travail sur les valvulopathies de la Societe francaise de cardiologi. de Gevigney G, et al. Arch Mal Coeur Vaiss. 2007 Jan;100 Spec No 1:19-28. Arch Mal Coeur Vaiss. 2007. PMID: 17405561 Review. French.
Cited by
- A Proof of Concept Study of Using Machine-Learning in Artificial Aortic Valve Design: From Leaflet Design to Stress Analysis.
Liang L, Sun B. Liang L, et al. Bioengineering (Basel). 2019 Nov 8;6(4):104. doi: 10.3390/bioengineering6040104. Bioengineering (Basel). 2019. PMID: 31717333 Free PMC article. - Temporal, biomechanical evaluation of a novel, transcatheter polymeric aortic valve in ovine aortic banding model.
Kachel M, Buszman PP, Milewski KP, Michalak M, Domaradzki W, Pruski M Jr, Sobota M, Fernandez C, Konopko M, Nożyński J, Kaźmierczak P, Włodarczyk J, Stojko M, Bochenek A, Buszman PE. Kachel M, et al. Front Cardiovasc Med. 2022 Dec 20;9:977006. doi: 10.3389/fcvm.2022.977006. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36606288 Free PMC article. - 6-Month Evaluation of a Transcatheter Aortic Valve (Myval) in a Novel Ovine, Supra-Aortic Banding Model.
Buszman PP, Kachel M, Ceballos CF, Łukasik K, Domaradzki W, Pruski M Jr, Tellez A, Rousselle S, Konopko M, Glanc M, Kaźmierczak P, Milewski KP, Buszman PE. Buszman PP, et al. JACC Basic Transl Sci. 2022 May 11;7(5):486-495. doi: 10.1016/j.jacbts.2022.01.008. eCollection 2022 May. JACC Basic Transl Sci. 2022. PMID: 35663633 Free PMC article. - The Odyssey of TAVR from concept to clinical reality.
Cribier AG. Cribier AG. Tex Heart Inst J. 2014 Apr 1;41(2):125-30. doi: 10.14503/THIJ-14-4137. eCollection 2014 Apr. Tex Heart Inst J. 2014. PMID: 24808769 Free PMC article. No abstract available. - Invention and uptake of TAVI over the first 20 years.
Cribier A. Cribier A. Nat Rev Cardiol. 2022 Jul;19(7):427-428. doi: 10.1038/s41569-022-00721-w. Nat Rev Cardiol. 2022. PMID: 35641651 No abstract available.